About Us
We are Curaleaf International, part of the world’s leading cannabis company.
Through innovation, research, education and clinical excellence we are shining a light on the possibilities of cannabis and leading the global cannabis industry towards a bright future of superior products and widespread acceptance.
What we do
We handle cannabis all the way from plant to patient through a global, integrated supply chain and valued partnerships. From cultivation, manufacturing, extraction, distribution and prescribing, we deliver unrivalled quality, reliability and consistency.
We work closely with healthcare professionals, policymakers, and patient communities to shape a future where evidence-based, cannabis-based therapies are readily available to the people who need them.
Leading the way
The growth of Curaleaf International
- EMMAC Life Sciences was founded
- Research collaboration with Imperial College London
- Creation of the UK Medical Cannabis Registry, capturing real world evidence and now the largest of its kind in Europe
- Majority acquisition of certified laboratory in Spain
- Acquisition of leading UK specials manufacturer
- Acquisition of Portuguese genetics and cultivation company
- Product launched in UK market
- First European cannabis company licensed to manufacture medical cannabis active pharmaceutical ingredients with THC
- Launch of the UK’s first online medical cannabis pharmacy
- Selected as part of the French medical cannabis trial in partnership with Boiron
- Curaleaf Holdings Inc acquire EMMAC Life Sciences which becomes Curaleaf International
- Registration of the first THC cannabis extract API in Italy with local partner
- Acquisition of the highest rated medical cannabis clinic in the UK
- Partnership and majority acquisition of leading German producer and distributor of medical cannabis Four 20 Pharma
- Acquisition of EU GMP facility in Portugal to streamline and accelerate operations to serve the rapidly growing European market
- Acquisition of Polish wholesaler specialising in medical cannabis
- Acquisition of Northern Green Canada, leading licensed cultivator and EU GMP processor of medical cannabis
- Acquisition of Fitokan, a leading medical cannabis clinic in Poland, known for clinical quality, education and patient care with multiple physical clinic locations
We are global
Curaleaf International is a division of Curaleaf Holdings Inc., a leading medical and adult use cannabis business in the United States, with a broad portfolio of dispensaries, cultivation sites and product brands.
As part of the Curaleaf family, our global expertise, combined with local knowledge, enables us to support diverse patient populations while meeting regulatory compliance. With a full suite of licences and a wide sales network, we are building solutions for patients, prescribers, and partners across Europe and the rest of the world.
- Operations & Sales
- Export Sales Only
- Operations Only
- Operations & Sales
- Export Sales Only
- Operations Only
Our Executive Team
Join us in shaping the future
We are always looking for people with passion, talent and curiosity, who share our vision and want to explore the potential of medical cannabis to enhance lives across the world. Whether you’re a scientist, healthcare professional, or business expert, Curaleaf International offers opportunities to grow, innovate, and contribute to a rapidly evolving sector.
Find your future with Curaleaf International.
Reach out
Looking to connect with Curaleaf International? Whether you’re a healthcare professional, business partner, or patient advocate, we’re here to collaborate and support the future of medical cannabis. Contact us to learn more about how we can work together.